- Home
- VOXX vs CGEN Comparison
VOXX vs CGEN Comparison
Compare VOXX & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOXX
- CGEN
- Stock Information
- Founded
- VOXX 1960
- CGEN 1993
- Country
- VOXX United States
- CGEN Israel
- Employees
- VOXX N/A
- CGEN N/A
- Industry
- VOXX Electronic Components
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VOXX Technology
- CGEN Health Care
- Exchange
- VOXX Nasdaq
- CGEN Nasdaq
- Market Cap
- VOXX 176.1M
- CGEN 142.8M
- IPO Year
- VOXX 1987
- CGEN 2000
- Fundamental
- Price
- VOXX $7.30
- CGEN $1.53
- Analyst Decision
- VOXX
- CGEN Strong Buy
- Analyst Count
- VOXX 0
- CGEN 1
- Target Price
- VOXX N/A
- CGEN $4.00
- AVG Volume (30 Days)
- VOXX 257.9K
- CGEN 490.9K
- Earning Date
- VOXX 01-07-2025
- CGEN 11-12-2024
- Dividend Yield
- VOXX N/A
- CGEN N/A
- EPS Growth
- VOXX N/A
- CGEN N/A
- EPS
- VOXX N/A
- CGEN 0.02
- Revenue
- VOXX $427,492,000.00
- CGEN $59,852,000.00
- Revenue This Year
- VOXX $7.88
- CGEN $57.27
- Revenue Next Year
- VOXX $7.24
- CGEN N/A
- P/E Ratio
- VOXX N/A
- CGEN $85.40
- Revenue Growth
- VOXX N/A
- CGEN 698.03
- 52 Week Low
- VOXX $2.27
- CGEN $1.35
- 52 Week High
- VOXX $11.31
- CGEN $3.03
- Technical
- Relative Strength Index (RSI)
- VOXX 46.55
- CGEN 44.44
- Support Level
- VOXX $7.15
- CGEN $1.44
- Resistance Level
- VOXX $7.95
- CGEN $1.68
- Average True Range (ATR)
- VOXX 0.37
- CGEN 0.09
- MACD
- VOXX -0.05
- CGEN -0.00
- Stochastic Oscillator
- VOXX 25.77
- CGEN 33.33
About VOXX VOXX International Corporation
VOXX International Corp manufacturer and distributor in the Automotive Electronics, Consumer Electronics, and Biometrics industries. The consumer electronic products primarily consist of finished goods sold to retail and commercial customers, consisting of premium audio and other consumer electronic products. Automotive products, some of which are manufactured by the Company, are sold both to OEM and aftermarket customers. Biometric products, primarily consisting of finished goods, are sold to retail and commercial customers.
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.